-
Most Recent
Search Results
240 results for TRAN
This Tiny AI Stock Exploded Higher … Here’s How to Spot the Next One
In today’s issue, Louis Navellier explains what his system was seeing at the time, and why he believes similar setups are beginning to appear again…
No Frills, Just Thrills for Air Tran at Southwest Offer
Southwest Airlines Co. (NYSE: LUV) has made an offer to buy competitor AirTran Holdings, Inc. (NYSE: AAI) for about $1.4 billion in cash and Southwest…
Trans Fats Ban: FDA Gives Companies Until 2018 to Comply
The FDA is giving companies until 2018 to remove trans fats from their foods in an effort to reduce costs and save lives.
Wall Street Let AI Pick Stocks and Here Is What Happened
Longtime Digest readers know how bullish we are on the AI Megatrend. We’ve tried hard to keep our readers in profitable trades involving semiconductors, AI…
TransCanada Corporation (USA) (TRP): Donald Trump Voices Support for Keystone Pipeline
Comments from Donald Trump have given some life back to the Keystone Pipeline — and even without it, TransCanada (TRP) has a lot going on.
TRXC Stock: 14 Things for Investors to Know as TransEnterix Rockets Higher
Digital laparoscopy play TRXC stock is on the move Monday. Here’s what you should know about the company TransEnterix right now.
TransUnion Stock Soars on Q1 Earnings Beat
TransUnion (TRU) stock was flying high on Friday following the release of its earnings report for the first quarter of 2018.
TransEnterix Doesn’t Have What It Takes to Be a Long-Term Investment
TransEnterix is facing competition from a number of much larger companies, while its revenue is quite low. Investors should take profits on TRXC stock.
Burt Reynolds Unveils Limited Edition Firebird Trans Am Bandit
Acting legend Burt Reynolds is unveiling a modern version of the Firebird Trans Am–the vehicle that he made his name with in ‘Smokey and the…
TransAsia Airways Crash: Horrifying Video as Plane Clips Bridge
Video footage of the TransAsia Airways crash that resulted in 26 people dead and 17 missing has been uploaded to YouTube.
Why Is TransCode Therapeutics (RNAZ) Stock Up 30% Today?
RNAZ stock is powering higher today as TransCode Therapeutics cracks the code to an RNA-based cancer treatment.
Watch for an Exxon Discount on TransCanada
The recent spill from Exxon’s Pegasus pipeline has environmentalists once again barking at the Keystone XL, which could help bring down the price on an…
$725 Billion and Counting: Why the AI Gusher Is Just Getting Started
The Mag 7 committed $725B to AI capex with no peak in sight. Here are the downstream AI stocks positioned to catch the windfall.
Why Is TransCode Therapeutics (RNAZ) Stock Up 240% Today?
With TransCode Therapeutics delivering positive pre-clinical results for its brain tumor candidate, RNAZ stock soared on the implications.
Make a Surgical Strike With TransEnterix Stock
As TRXC stock takes a breather amid a sustained uptrend, investors should consider owning shares of this medical robotics innovator.
TransEnterix Has Strong Funding and a Burgeoning Market
TRXC stock could become the next Intuitive Surgical. The company is funded, and has to simply develop its business now.
Time To Buy Enbridge and Sell TransCanada
With Enbridge beating TransCanada on most fronts, investors can expect ENB’s tax-advantaged dividend growth to continue.
Hold TransEnterix Stock as This Tiny Company Has Big Potential
Surgical robotics is a fascinating market niche with huge potential, and you can capitalize on its expansion with a position in TRXC stock.
Why Is TransCode Therapeutics (RNAZ) Stock Down 25% Today?
TransCode Therapeutics stock is falling on Friday after the company announced plans for a public offering of RNAZ shares.
5 Reasons Not to LUV the Southwest-AirTran Merger Right Now
The Southwest-AirTran merger could pay off eventually, but there’s numerous factors and a boatload of past precedent that shows the near future will be rocky.
RNAZ Stock Earnings: TransCode Therapeutics Misses EPS for Q2 2024
RNAZ stock results show that TransCode Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
RNAZ Stock Earnings: TransCode Therapeutics Misses EPS for Q1 2024
RNAZ stock results show that TransCode Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
The AI Story Is Changing – And So Will the Market Leaders
In today’s Market 360, I want to explain what AI agents really are, how they emerged so quickly and why they could become far more…
6 – 10 of 240 results
